Hospira Issues Voluntary Recall of Sodium Chloride Injection, 0.9 Percent, 1000 mL, Flexible Container: Brass Particulates
Sterile injectables maker Hospira has issued a voluntary nationwide user-level recall of one lot of 0.9 % Sodium Chloride Injection, USP, 1000 mL, Flexible Container, NDC 0409-7983-09. This action is due to a confirmed customer report where brass particulate was identified in the primary conainter in the form of several small grey/brown particles. The affected lot number is 25-037-JT (the lot number may be followed by a -01 or -90), with an expiration date of January 1, 2015. Hospira is investigating to determine the root cause.
Click here to read a MedWatch Safety Information Alert on this recall.
In February 2013, Hospira, an FDA-registered manufacturer, issued a recall of three lots of propofol injectable emulsion after reports came to light that some vials had visible particles embedded in the glass.
Click here to read more about Hospira's February 2013 recall.